Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

A noninvasive diagnostic approach using per-rectal portal scintigraphy for sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation.

Okamura H, Koh H, Takakuwa T, Ido K, Makuuchi Y, Ine S, Nanno S, Nakashima Y, Nakane T, Jogo A, Yamamoto A, Hamuro M, Kotani K, Kawabe J, Higashiyama S, Yoshida A, Shiomi S, Ohsawa M, Hino M, Nakamae H.

Bone Marrow Transplant. 2019 May 14. doi: 10.1038/s41409-019-0537-x. [Epub ahead of print] No abstract available.

PMID:
31089276
2.

Unit selection for umbilical cord blood transplantation for adults with acute myeloid leukemia in complete remission: a Japanese experience.

Yanada M, Konuma T, Kuwatsuka Y, Kondo T, Kawata T, Takahashi S, Uchida N, Miyakoshi S, Tanaka M, Ozawa Y, Sawa M, Nakamae H, Aotsuka N, Kanda J, Takanashi M, Kanda Y, Atsuta Y, Yano S.

Bone Marrow Transplant. 2019 May 8. doi: 10.1038/s41409-019-0539-8. [Epub ahead of print]

PMID:
31068659
3.

Short-Term Fasting Induces Cell Cycle Arrest in Immature Hematopoietic Cells and Increases the Number of Naïve T Cells in the Bone Marrow of Mice.

Takakuwa T, Nakashima Y, Koh H, Nakane T, Nakamae H, Hino M.

Acta Haematol. 2019;141(3):189-198. doi: 10.1159/000496096. Epub 2019 Mar 6.

PMID:
30840964
4.

The Proportional Relationship between Pre-transplant WT1 mRNA Levels and Risk of Mortality after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Not in Remission.

Ido K, Nakamae M, Koh H, Okamura H, Nanno S, Nishimoto M, Takeoka Y, Hirose A, Nakashima Y, Hashimoto Y, Nakane T, Hino M, Nakamae H.

Transplantation. 2019 Feb 11. doi: 10.1097/TP.0000000000002662. [Epub ahead of print]

PMID:
30801534
5.

Cytomegalovirus reactivation is associated with increased mortality more than 100 days after allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma.

Sawayama Y, Itonaga H, Fukushima T, Nakano N, Fujiwara H, Utsunomiya A, Fukuda T, Miyamoto T, Eto T, Miyashita K, Nakamae H, Ogata M, Yamanoha A, Miyazaki Y, Kanda J, Atsuta Y, Kato K; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 May;94(5):E143-E146. doi: 10.1002/ajh.25438. Epub 2019 Mar 6. No abstract available.

PMID:
30773707
6.

[Refractory ascites caused by lymphatic flow disorder after stem cell transplantation for acute myeloid leukemia].

Takakuwa T, Okuno T, Nishimoto M, Nanno S, Takeoka Y, Nakashima Y, Koh H, Nakane T, Wanibuchi H, Hino M, Nakamae H.

Rinsho Ketsueki. 2019;60(1):12-16. doi: 10.11406/rinketsu.60.12. Japanese.

PMID:
30726817
7.

Clinical significance of low-dose total body irradiation in HLA-mismatched reduced-intensity stem cell transplantation.

Fujiwara SI, Kanda J, Tatara R, Ogawa H, Fukuda T, Okumura H, Ohashi K, Iwato K, Ueda Y, Ishiyama K, Eto T, Matsuoka KI, Nakamae H, Onizuka M, Atsuta Y, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Bone Marrow Transplant. 2019 Jan 22. doi: 10.1038/s41409-019-0434-3. [Epub ahead of print]

PMID:
30670824
8.

[Successful treatment with rituximab in acute disseminated encephalomyelitis with whole spinal cord involvement following HLA haploidentical transplantation].

Makuuchi Y, Nishimoto M, Yamamoto K, Takahashi T, Kuno M, Nakashima Y, Koh H, Nakane T, Hino M, Nakamae H.

Rinsho Ketsueki. 2018;59(12):2588-2593. doi: 10.11406/rinketsu.59.2588. Japanese.

PMID:
30626794
9.

Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.

Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S, Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata M, Atsuta Y, Teshima T; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Blood Adv. 2019 Jan 22;3(2):105-115. doi: 10.1182/bloodadvances.2018025643.

10.

HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome.

Maeda Y, Ugai T, Kondo E, Ikegame K, Murata M, Uchida N, Miyamoto T, Takahashi S, Ohashi K, Nakamae H, Fukuda T, Onizuka M, Eto T, Ota S, Hirokawa M, Ichinohe T, Atsuta Y, Kanda Y, Kanda J; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Haematologica. 2019 May;104(5):1055-1061. doi: 10.3324/haematol.2018.204438. Epub 2018 Dec 6.

11.

Successful treatment of invasive pulmonary aspergillosis caused by Aspergillus felis, a cryptic species within the Aspergillus section Fumigati: A case report.

Yamairi K, Ido K, Nakamura S, Niki M, Imoto W, Shibata W, Namikawa H, Fujimoto H, Yamada K, Nakamae H, Hino M, Kaneko Y, Miyazaki Y, Kakeya H.

J Infect Chemother. 2019 Apr;25(4):307-310. doi: 10.1016/j.jiac.2018.10.016. Epub 2018 Nov 30.

PMID:
30503017
12.

Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Kawata T, Mizuta S, Ago H, Chou T, Yamane T, Uchiyama H, Oyake T, Miura K, Saito B, Taji H, Nakamae H, Miyamoto T, Fukuda T, Kanda J, Atsuta Y, Suzuki R.

Int J Hematol. 2019 Feb;109(2):175-186. doi: 10.1007/s12185-018-2560-x. Epub 2018 Nov 14.

PMID:
30430419
13.

Upfront allogeneic hematopoietic cell transplantation (HCT) versus remission induction chemotherapy followed by allogeneic HCT for acute myeloid leukemia with multilineage dysplasia: A propensity score matched analysis.

Konuma T, Harada K, Yamasaki S, Mizuno S, Uchida N, Takahashi S, Onizuka M, Nakamae H, Hidaka M, Fukuda T, Ohashi K, Kohno A, Matsushita A, Kanamori H, Ashida T, Kanda J, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Am J Hematol. 2019 Jan;94(1):103-110. doi: 10.1002/ajh.25336. Epub 2018 Nov 29.

PMID:
30370944
14.

Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis.

Konuma T, Shimomura Y, Ozawa Y, Ueda Y, Uchida N, Onizuka M, Akiyama M, Mori T, Nakamae H, Ohno Y, Shiratori S, Onishi Y, Kanda Y, Fukuda T, Atsuta Y, Ishiyama K; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Hematol Oncol. 2019 Feb;37(1):85-95. doi: 10.1002/hon.2566. Epub 2018 Nov 19.

PMID:
30370627
15.

The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.

Kato K, Uike N, Wake A, Yoshimitsu M, Tobai T, Sawayama Y, Takatsuka Y, Fukuda T, Uchida N, Eto T, Nakashima Y, Kondo T, Taguchi J, Miyamoto T, Nakamae H, Ichinohe T, Kato K, Suzuki R, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Hematol Oncol. 2019 Feb;37(1):54-61. doi: 10.1002/hon.2558. Epub 2018 Sep 28.

PMID:
30171618
16.

Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades.

Yanada M, Masuko M, Mori J, Aoki J, Mizuno S, Fukuda T, Kakihana K, Ozawa Y, Ota S, Kanamori H, Mori T, Nakamae H, Eto T, Shiratori S, Maeda T, Iwato K, Ichinohe T, Kanda Y, Tanaka J, Atsuta Y, Yano S.

Bone Marrow Transplant. 2019 Apr;54(4):578-586. doi: 10.1038/s41409-018-0301-7. Epub 2018 Aug 14.

PMID:
30108330
17.

Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation.

Inamoto Y, Matsuda T, Tabuchi K, Kurosawa S, Nakasone H, Nishimori H, Yamasaki S, Doki N, Iwato K, Mori T, Takahashi S, Yabe H, Kohno A, Nakamae H, Sakura T, Hashimoto H, Sugita J, Ago H, Fukuda T, Ichinohe T, Atsuta Y, Yamashita T; Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group.

Blood Adv. 2018 Aug 14;2(15):1901-1913. doi: 10.1182/bloodadvances.2018020966.

18.

Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Konuma T, Mizuno S, Kondo T, Yamaguchi H, Fukuda T, Uchida N, Najima Y, Kanamori H, Ota S, Nakamae H, Nakamae M, Mizuno I, Sugita J, Onishi Y, Yokota A, Takahashi S, Kanda Y, Ichinohe T, Atsuta Y, Yano S; Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Ann Hematol. 2018 Nov;97(11):2173-2183. doi: 10.1007/s00277-018-3419-1. Epub 2018 Jul 6.

PMID:
29978286
19.

Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia.

Hashimoto Y, Nakamae H, Tanaka T, Omura H, Horiuchi M, Yoshimura T, Takakuwa T, Mugitani A, Hirose A, Nakamae M, Koh H, Hino M.

Eur J Haematol. 2018 Oct;101(4):508-513. doi: 10.1111/ejh.13136. Epub 2018 Aug 31.

PMID:
29971894
20.

Final 3-year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second-line Treatment.

Okada M, Imagawa J, Tanaka H, Nakamae H, Hino M, Murai K, Ishida Y, Kumagai T, Sato S, Ohashi K, Sakamaki H, Wakita H, Uoshima N, Nakagawa Y, Minami Y, Ogasawara M, Takeoka T, Akasaka H, Utsumi T, Uike N, Sato T, Ando S, Usuki K, Mizuta S, Hashino S, Nomura T, Shikami M, Fukutani H, Ohe Y, Kosugi H, Shibayama H, Maeda Y, Fukushima T, Yamazaki H, Tsubaki K, Kukita T, Adachi Y, Nataduka T, Sakoda H, Yokoyama H, Okamoto T, Shirasugi Y, Onishi Y, Nohgawa M, Yoshihara S, Morita S, Sakamoto J, Kimura S; DADI Trial Group, Japan.

Clin Lymphoma Myeloma Leuk. 2018 May;18(5):353-360.e1. doi: 10.1016/j.clml.2018.03.004. Epub 2018 Mar 15.

21.

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).

Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y.

Int J Hematol. 2018 May;107(5):535-540. doi: 10.1007/s12185-018-2401-y. Epub 2018 Jan 23.

PMID:
29362980
22.

The First Case of Non-leukemic Sarcoma Composed of Mixed-phenotype Acute Leukemia, B/myeloid, Not Otherwise Specified.

Takakuwa T, Nakane T, Ohsawa M, Nagasaki J, Aoyama Y, Nishimoto M, Hayashi Y, Kuwae Y, Hino M, Nakamae H.

Intern Med. 2018 Apr 15;57(8):1155-1158. doi: 10.2169/internalmedicine.9144-17. Epub 2017 Dec 21.

23.

Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia.

Arima N, Kanda J, Tanaka J, Yabe T, Morishima Y, Kim SW, Najima Y, Ozawa Y, Eto T, Kanamori H, Mori T, Kobayashi N, Kondo T, Nakamae H, Uchida N, Inoue M, Fukuda T, Ichinohe T, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Apr;24(4):717-725. doi: 10.1016/j.bbmt.2017.11.029. Epub 2017 Dec 27.

24.

Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation.

Yamamoto C, Ogawa H, Fukuda T, Igarashi A, Okumura H, Uchida N, Hidaka M, Nakamae H, Matsuoka KI, Eto T, Ichinohe T, Atsuta Y, Kanda Y.

Biol Blood Marrow Transplant. 2018 Apr;24(4):708-716. doi: 10.1016/j.bbmt.2017.10.043. Epub 2017 Nov 28.

25.

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: long-term follow-up of the Japanese subgroup of the randomized ENESTnd trial.

Nakamae H, Fukuda T, Nakaseko C, Kanda Y, Ohmine K, Ono T, Matsumura I, Matsuda A, Aoki M, Ito K, Shibayama H.

Int J Hematol. 2018 Mar;107(3):327-336. doi: 10.1007/s12185-017-2353-7. Epub 2017 Oct 26.

PMID:
29076005
26.

Picosecond tunable gain-switched blue pulses from GaN laser diodes with nanosecond current injections.

Chen S, Nakamura T, Ito T, Bao X, Nakamae H, Weng G, Hu X, Yoshita M, Akiyama H, Liu J, Ikeda M, Yang H.

Opt Express. 2017 Jun 12;25(12):13046-13054. doi: 10.1364/OE.25.013046.

PMID:
28788844
27.

An Elderly Woman with Anti-neutrophil Antibody-positive Agranulocytosis Who Responded to High-dose Intravenous Methylprednisolone.

Koh S, Koh H, Kubo Y, Kuroda M, Nishimoto M, Yoshimura T, Nakashima Y, Nakane T, Nakamae H, Ohsawa M, Hino M.

Intern Med. 2017 Aug 15;56(16):2199-2203. doi: 10.2169/internalmedicine.8268-16. Epub 2017 Aug 1.

28.

Diagnostic value of serum ferritin and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation: methodological issues.

Koh H, Nanno S, Hino M, Nakamae H.

Leuk Lymphoma. 2018 Mar;59(3):772-773. doi: 10.1080/10428194.2017.1361033. Epub 2017 Aug 4. No abstract available.

PMID:
28776428
29.

Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.

Kasashima H, Yashiro M, Nakamae H, Masuda G, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Nakane T, Hino M, Hirakawa K, Ohira M.

PLoS One. 2017 Jun 2;12(6):e0178635. doi: 10.1371/journal.pone.0178635. eCollection 2017.

30.

Clinical impact of pretransplant use of multiple tyrosine kinase inhibitors on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia.

Kondo T, Nagamura-Inoue T, Tojo A, Nagamura F, Uchida N, Nakamae H, Fukuda T, Mori T, Yano S, Kurokawa M, Ueno H, Kanamori H, Hashimoto H, Onizuka M, Takanashi M, Ichinohe T, Atsuta Y, Ohashi K.

Am J Hematol. 2017 Sep;92(9):902-908. doi: 10.1002/ajh.24793. Epub 2017 Jun 9.

31.

Autonomic Nervous System Pretransplant Malfunction Is a Powerful Predictor of Survival After Allogeneic Hematopoietic Cell Transplantation.

Nakane T, Nakamae M, Koh H, Nishimoto M, Nakashima Y, Hirose A, Hino M, Nakamae H.

Transplantation. 2017 Nov;101(11):2801-2809. doi: 10.1097/TP.0000000000001813.

PMID:
28505024
32.

Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study.

Tojo A, Kyo T, Yamamoto K, Nakamae H, Takahashi N, Kobayashi Y, Tauchi T, Okamoto S, Miyamura K, Hatake K, Iwasaki H, Matsumura I, Usui N, Naoe T, Tugnait M, Narasimhan NI, Lustgarten S, Farin H, Haluska F, Ohyashiki K.

Int J Hematol. 2017 Sep;106(3):385-397. doi: 10.1007/s12185-017-2238-9. Epub 2017 Apr 25.

PMID:
28444644
33.

Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation.

Nishimoto M, Koh H, Tokuwame A, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Koh S, Yoshimura T, Nanno S, Nakamae M, Hirose A, Nakashima Y, Nakane T, Hino M, Nakamae H.

Br J Clin Pharmacol. 2017 Sep;83(9):2000-2007. doi: 10.1111/bcp.13303. Epub 2017 May 24.

34.

Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma.

Yamasaki S, Suzuki R, Hatano K, Fukushima K, Iida H, Morishima S, Suehiro Y, Fukuda T, Uchida N, Uchiyama H, Ikeda H, Yokota A, Tsukasaki K, Yamaguchi H, Kuroda J, Nakamae H, Adachi Y, Matsuoka KI, Nakamura Y, Atsuta Y, Suzumiya J.

Bone Marrow Transplant. 2017 Jul;52(7):969-976. doi: 10.1038/bmt.2017.52. Epub 2017 Apr 3.

PMID:
28368379
35.

Dasatinib versus imatinib in Japanese patients with newly diagnosed chronic phase chronic myeloid leukemia: a subanalysis of the DASISION 5-year final report.

Nakamae H, Fujisawa S, Ogura M, Uchida T, Onishi Y, Taniwaki M, Utsunomiya A, Matsue K, Takamatsu Y, Usuki K, Tanimoto M, Ishida Y, Ohashi K, Li L, Miyoshi M.

Int J Hematol. 2017 Jun;105(6):792-804. doi: 10.1007/s12185-017-2208-2. Epub 2017 Mar 24.

PMID:
28341918
36.

Dasatinib and Prednisolone Induction Therapy for a Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Dilated Cardiomyopathy Accompanied by Life-Threatening Ventricular Tachycardia.

Nishimoto M, Nakamae H, Matsumoto K, Morita K, Koga Y, Momose D, Hino M.

Case Rep Hematol. 2017;2017:4027908. doi: 10.1155/2017/4027908. Epub 2017 Feb 23.

37.

Diagnostic usefulness of plasma presepsin (soluble CD14-subtype) for diagnosing hemophagocytic syndrome in hematological malignancies.

Koh H, Nanno S, Katayama T, Hirose A, Nakamae M, Hino M, Nakamae H.

Leuk Lymphoma. 2017 Oct;58(10):2489-2492. doi: 10.1080/10428194.2017.1292356. Epub 2017 Feb 28. No abstract available.

PMID:
28278703
38.

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation for younger patients with acute myeloid leukemia: a registry-based study.

Yanada M, Kurosawa S, Kobayashi T, Ozawa Y, Kanamori H, Kobayashi N, Sawa M, Nakamae H, Uchida N, Hashimoto H, Fukuda T, Hirokawa M, Atsuta Y, Yano S.

Bone Marrow Transplant. 2017 Jun;52(6):818-824. doi: 10.1038/bmt.2016.358. Epub 2017 Jan 23.

PMID:
28112749
39.

Use of mycophenolate mofetil and a calcineurin inhibitor in allogeneic hematopoietic stem-cell transplantation from HLA-matched siblings or unrelated volunteer donors: Japanese multicenter phase II trials.

Nakane T, Nakamae H, Yamaguchi T, Kurosawa S, Okamura A, Hidaka M, Fuji S, Kohno A, Saito T, Aoyama Y, Hatanaka K, Katayama Y, Yakushijin K, Matsui T, Yamamori M, Takami A, Hino M, Fukuda T.

Int J Hematol. 2017 Apr;105(4):485-496. doi: 10.1007/s12185-016-2154-4. Epub 2016 Dec 9.

PMID:
27943166
40.

Diagnostic value of serum ferritin and the risk factors and cytokine profiles of hemophagocytic syndrome following allogeneic hematopoietic cell transplantation.

Nanno S, Koh H, Nakashima Y, Katayama T, Okamura H, Koh S, Yoshimura T, Nishimoto M, Hayashi Y, Nakamae M, Hirose A, Nakane T, Hino M, Nakamae H.

Leuk Lymphoma. 2017 Jul;58(7):1664-1672. doi: 10.1080/10428194.2016.1262034. Epub 2016 Dec 6.

PMID:
27919187
41.

Low-dose thymoglobulin as second-line treatment for steroid-resistant acute GvHD: an analysis of the JSHCT.

Murata M, Ikegame K, Morishita Y, Ogawa H, Kaida K, Nakamae H, Ikeda T, Nishida T, Inoue M, Eto T, Kubo K, Sakura T, Mori T, Uchida N, Ashida T, Matsuhashi Y, Miyazaki Y, Ichinohe T, Atsuta Y, Teshima T.

Bone Marrow Transplant. 2017 Feb;52(2):252-257. doi: 10.1038/bmt.2016.247. Epub 2016 Nov 21.

PMID:
27869808
42.

CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.

Kasashima H, Yashiro M, Nakamae H, Kitayama K, Masuda G, Kinoshita H, Fukuoka T, Hasegawa T, Nakane T, Hino M, Hirakawa K, Ohira M.

Am J Pathol. 2016 Nov;186(11):3028-3039. doi: 10.1016/j.ajpath.2016.07.024. Epub 2016 Oct 11.

PMID:
27742059
43.

Allogeneic Hematopoietic Cell Transplantation for Leukemic Transformation Preceded by Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Nationwide Survey by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Takagi S, Masuoka K, Uchida N, Kurokawa M, Nakamae H, Imada K, Iwato K, Ichinohe T, Atsuta Y, Takami A, Yano S.

Biol Blood Marrow Transplant. 2016 Dec;22(12):2208-2213. doi: 10.1016/j.bbmt.2016.09.017. Epub 2016 Sep 22.

44.

Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.

Kobayashi R, Mitsui T, Fujita N, Osumi T, Aoki T, Aoki K, Suzuki R, Fukuda T, Miyamoto T, Kato K, Nakamae H, Goto H, Eto T, Inoue M, Mori T, Terui K, Onizuka M, Koh K, Koga Y, Ichinohe T, Sawada A, Atsuta Y, Suzumiya J.

Int J Hematol. 2017 Mar;105(3):369-376. doi: 10.1007/s12185-016-2120-1. Epub 2016 Oct 27.

PMID:
27787746
45.

An Open-labeled, Multicenter Phase II Study of Tamibarotene in Patients with Steroid-refractory Chronic Graft-versus-Host Disease.

Maeda Y, Nishimori H, Inamoto Y, Nakamae H, Sawa M, Mori Y, Ohashi K, Fujiwara SI, Tanimoto M.

Acta Med Okayama. 2016 Oct;70(5):409-412.

46.

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.

Konuma T, Miyazaki Y, Uchida N, Ohashi K, Kondo T, Nakamae H, Takahashi S, Mori T, Ozawa Y, Kato C, Iwato K, Fukuda T, Ichinohe T, Atsuta Y, Ishiyama K; Adult Myelodysplastic Syndrome Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2017 Jan;23(1):75-80. doi: 10.1016/j.bbmt.2016.10.015. Epub 2016 Oct 21.

47.

Combinational approach using in situ hybridization targeting 23S ribosomal RNA genes and blood cultures for bacterial identification in patients with neutropenia and fever.

Koh H, Aimoto M, Matsuhisa A, Inoue S, Katayama T, Okamura H, Yoshimura T, Koh S, Nanno S, Nishimoto M, Nakashima Y, Hirose A, Nakamae M, Nakane T, Hino M, Nakamae H.

J Infect Chemother. 2016 Oct;22(10):697-703. doi: 10.1016/j.jiac.2016.08.001. Epub 2016 Aug 28.

PMID:
27581389
48.

Plasma Kinetics of Th1, Th2 and Th17 Cytokines in Polymyositis Related to Chronic Graft-versus-Host Disease.

Koh S, Koh H, Nakashima Y, Katayama T, Sakabe M, Okamura H, Yoshimura T, Nanno S, Nishimoto M, Hayashi Y, Nakane T, Nakamae H, Ohsawa M, Hino M.

Intern Med. 2016;55(16):2265-70. doi: 10.2169/internalmedicine.55.6206. Epub 2016 Aug 15.

49.

Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies.

Nanno S, Koh H, Katayama T, Hashiba M, Sato A, Makuuchi Y, Nagasaki J, Kuno M, Yoshimura T, Okamura H, Nishimoto M, Hirose A, Nakamae M, Nakane T, Hino M, Nakamae H.

Intern Med. 2016;55(16):2173-84. doi: 10.2169/internalmedicine.55.6524. Epub 2016 Aug 15.

50.

Prognostic Effect of Low Subcutaneous Adipose Tissue on Survival Outcome in Patients With Multiple Myeloma.

Takeoka Y, Sakatoku K, Miura A, Yamamura R, Araki T, Seura H, Okamura T, Koh H, Nakamae H, Hino M, Ohta K.

Clin Lymphoma Myeloma Leuk. 2016 Aug;16(8):434-41. doi: 10.1016/j.clml.2016.04.010. Epub 2016 May 4.

PMID:
27263047

Supplemental Content

Loading ...
Support Center